| __timestamp | Exelixis, Inc. | Jazz Pharmaceuticals plc |
|---|---|---|
| Wednesday, January 1, 2014 | 25111000 | 1172875000 |
| Thursday, January 1, 2015 | 37172000 | 1324803000 |
| Friday, January 1, 2016 | 191454000 | 1487973000 |
| Sunday, January 1, 2017 | 452477000 | 1618693000 |
| Monday, January 1, 2018 | 853826000 | 1890922000 |
| Tuesday, January 1, 2019 | 967775000 | 2161761000 |
| Wednesday, January 1, 2020 | 987538000 | 2363567000 |
| Friday, January 1, 2021 | 1434970000 | 3094238000 |
| Saturday, January 1, 2022 | 1611062000 | 3659374000 |
| Sunday, January 1, 2023 | 1830208000 | 3834204000 |
| Monday, January 1, 2024 | 2168701000 |
Cracking the code
In the competitive landscape of biotechnology and pharmaceuticals, revenue generation is a key indicator of success. From 2014 to 2023, Jazz Pharmaceuticals plc consistently outperformed Exelixis, Inc. in terms of revenue. Jazz Pharmaceuticals saw a remarkable growth of over 227% during this period, peaking at approximately $3.8 billion in 2023. In contrast, Exelixis, Inc. experienced a significant increase of over 7,200%, reaching around $1.8 billion in the same year.
Despite Exelixis's impressive growth rate, Jazz Pharmaceuticals maintained a revenue advantage, generating nearly double the revenue of Exelixis by 2023. This trend highlights Jazz's strong market position and strategic growth initiatives. As the industry evolves, both companies continue to innovate, but Jazz's consistent revenue leadership underscores its robust business model and market strategy.
Eli Lilly and Company and Jazz Pharmaceuticals plc: A Comprehensive Revenue Analysis
Takeda Pharmaceutical Company Limited and Exelixis, Inc.: A Comprehensive Revenue Analysis
Alnylam Pharmaceuticals, Inc. vs Exelixis, Inc.: Examining Key Revenue Metrics
Revenue Insights: Biogen Inc. and Jazz Pharmaceuticals plc Performance Compared
Bio-Techne Corporation vs Jazz Pharmaceuticals plc: Examining Key Revenue Metrics
Exelixis, Inc. and Ionis Pharmaceuticals, Inc.: A Comprehensive Revenue Analysis
R&D Spending Showdown: Exelixis, Inc. vs Jazz Pharmaceuticals plc
Revenue Insights: Exelixis, Inc. and ImmunityBio, Inc. Performance Compared
Exelixis, Inc. vs Amphastar Pharmaceuticals, Inc.: Annual Revenue Growth Compared
Annual Revenue Comparison: Jazz Pharmaceuticals plc vs Halozyme Therapeutics, Inc.
Jazz Pharmaceuticals plc or Veracyte, Inc.: Who Leads in Yearly Revenue?
Jazz Pharmaceuticals plc vs Amphastar Pharmaceuticals, Inc.: Annual Revenue Growth Compared